Biological differences between fibroblasts derived from peripheral and central areas of keloid tissues

Plastic and Reconstructive Surgery

Volumn 120, Issue 3, 2007, Pages 625-630

  Lu, Feng ^b   Gao, Jianhua ^a   Ogawa, Rei ^b   Hyakusoku, Hiko ^b   Ou, Chunquan ^b  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

FAS ANTIBODY; FAS ANTIGEN; PROTEIN BCL 2; PROTEIN P53;

ADULT; APOPTOSIS; ARTICLE; CELL CYCLE; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL CYCLE S PHASE; CELL GROWTH; FEMALE; FIBROBLAST; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN TISSUE; KELOID; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADULT; APOPTOSIS; CELL CYCLE; CELL PROLIFERATION; FEMALE; FIBROBLASTS; HUMANS; KELOID; MALE; MIDDLE AGED;

EID: 34547911400     PISSN: 00321052     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.prs.0000270293.93612.7b     Document Type: Article

References (33)

1. Alhady, S. Keloids in various races. Plast. Reconstr. Surg. 44: 564, 1969.
2. Ladin, D. A., Garner, W. L., and Smith, D. J. Excessive scarring as a consequence of healing. Wound Repair Regen. 3: 6, 1995.
3. Nemeth, A. J. Keloids and hypertrophic scars. J. Dermatol. Surg. Oncol. 19: 738, 1993.
4. Russell, S. B., Trupin, K. M., Rodriguez-Eaton, S., Russell, J. D., and Trupin, J. S. Reduced growth-factor requirement of keloid derived fibroblasts may account for tumor growth. Proc. Natl. Acad. Sci. U.S.A. 85: 587, 1988.
5. Haisa, M., Okochi, H., and Grotendorst, G. Elevated levels of PDGF alpha receptors in keloid fibroblasts contribute to an enhanced response to PDGF. J. Invest. Dermatol. 103: 560, 1994.
6. Ladin, D. A., Hou, A., Patel, D., et al. p53 and apoptosis alterations in keloids and keloid fibroblasts. Wound Repair Regen. 6: 28, 1998.
7. Bao, W., Wang, C., and Zhu, H. Histological and morphological research on different areas of keloid. Chin. J. Plast. Surg. 11: 368, 1995.
8. Akasaka, Y., Fujita, K., Ishikawa, Y., et al. Detection of apoptosis in keloids and a comparative study on apoptosis between keloids, hypertrophic scars, normal healed flat scars, and dermatofibroma. Wound Repair Regen. 9: 501, 2001.
9. Chipev, C. C., Simman, R., Hatch, G., et al. Myofibroblast phenotype and apoptosis in keloid and palmar fibroblasts in vitro. Cell Death Differ. 7: 166, 2000.
10. Rockwell, W. B., Cohen, I. K., and Ehrlich, H. P. Keloids and hypertrophic scars: A comprehensive review. Plast. Reconstr. Surg. 84: 827, 1989.
11. Ehrlich, H. P., Desmouliere, A., Diegelmann, R. F., et al. Morphological and immunochemical differences between keloid and hypertrophic scar. Am. J. Pathol. 145: 105, 1994.
12. Abergel, R. P., Pizzurro, D., Merker, C. A., et al. Biochemical composition of the connective tissue in keloids and analysis of collagen metabolism in keloid fibroblast cultures. J. Invest. Dermatol. 84: 384, 1985.
13. Luo, S., Benathan, M., Raffoul, W., et al. Abnormal balance between proliferation and apoptotic cell death in fibroblasts derived from keloid lesions. Plast. Reconstr. Surg. 107: 87, 2001.
14. Phan, T. T., Lim, I. J., Chan, S. Y., Tan, E. K., Lee, S. T., and Longaker, M. T. Suppression of transforming growth factor beta/smad signaling in keloid-derived fibroblasts by quercetin: Implications for the treatment of excessive scars. J. Trauma 57: 1032, 2004.
15. Ehrlich, H. P., Desmouliere, A., Diegelmann, R. F., et al. Morphological and immunochemical differences between keloid and hypertrophic scar. Am. J. Pathol. 145: 105, 1994.
16. Lu, F., Gao, J. H., Ogawa, R., et al. Fas mediated apoptotic signal transduction in keloid and hypertrophic scar. Plast. Reconstr. Surg. 119: 1714, 2007.
17. Perry, D. K., and Hannun, Y. A. The use of diglyceride kinase for quantifying ceramide. Trends Biochem. Sci. 24: 226, 1999.
18. Hockenbery, D. M., Nunez, G., Milliman, C., Schreiber, R. D., and Korsmeyer, S. J. Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature 348: 334, 1990.
19. Nunez, G., London, L., Hockenbery, D., Alexander, M., McKearn, J. P., and Korsmeyer, S. J. Deregulated Bcl-2 gene expression selectively prolongs survival of growth factor-deprived hematopoietic cell lines. J. Immunol. 144: 3602, 1990.
20. Itoh, N., Tsujimoto, Y., and Nagata, S. Effect of bcl-2 on Fas antigen-mediated cell death. J. Immunol. 151: 621, 1993.
21. Shinoura, N., Yoshida, Y., Nishimura, M., et al. Expression level of Bcl-2 determines anti- or proapoptotic function. Cancer Res. 59: 4119, 1999.
22. Tuan, T. L., and Nichter, S. The molecular basis of keloid and hypertrophic scar formation. Mol. Med. Today 1: 19, 1998.
23. Chodon, T., Sugihara, T., Igawa, H. H., et al. Keloid-derived fibroblasts are refractory to Fas-mediated apoptosis and neutralization of autocrine transforming growth factor-beta1 can abrogate this resistance. Am. J. Pathol. 157: 1661, 2000.
24. Calderon, M., Lawrence, W. T., and Banes, A. J. Increased proliferation of keloid fibroblasts in vitro. J. Surg. Res. 61: 343, 1996.
25. Nakakao, H., Miyauchi, S., and Miki, Y. Proliferation activity of dermal fibroblasts in keloids and hypertrophic scars. Acta Dermatol. Venereol. (Stockh.) 75: 102, 1995.
26. Freiberg, R. A., Spencer, D. M., Choate, K. A., et al. Fas signal transduction triggers either proliferation or apoptosis in human fibroblasts. J. Invest. Dermatol. 108: 215, 1997.
27. Harris, A. L. Mutant p53: The commonest genetic abnormality in human cancer? J. Pathol. 162: 5, 1990.
28. Lane, D. P., and Benchimol, S. p53: Oncogene or anti-oncogene? Genes Dev. 4: 1, 1990.
29. Prives, C. How loops, sheets, and helices help us to understand p53. Cell 78: 543, 1994.
30. Levine, A. J. p53, the cellular gatekeeper for growth and division. Cell 88: 323, 1997.
31. Vousden, K. H. p53: Death star. Cell 103: 691, 2000.
32. Prives, C. Signaling to p53: Breaking the mdm2-p53 circuit. Cell 95: 5, 1998.
33. Crowe, D. L., and Sinha, U. K. p53 apoptotic response to DNA damage dependent on bcl-2 but not bax in head and neck squamous cell carcinoma lines. Head Neck 28: 15, 2006.